GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenetp Inc (OTCPK:RGTPQ) » Definitions » Cyclically Adjusted PB Ratio

Regenetp (Regenetp) Cyclically Adjusted PB Ratio : 0.00 (As of Apr. 27, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Regenetp Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Regenetp's current share price is $0.0699. Regenetp's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 was $47.66. Regenetp's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Regenetp's Cyclically Adjusted PB Ratio or its related term are showing as below:

RGTPQ's Cyclically Adjusted PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.715
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Regenetp's adjusted book value per share data for the three months ended in Mar. 2023 was $1.696. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $47.66 for the trailing ten years ended in Mar. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Regenetp Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Regenetp's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenetp Cyclically Adjusted PB Ratio Chart

Regenetp Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.31 0.25 0.08 0.09 0.01

Regenetp Quarterly Data
Apr18 Jul18 Oct18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.01 0.01 0.01 0.01

Competitive Comparison of Regenetp's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Regenetp's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenetp's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenetp's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Regenetp's Cyclically Adjusted PB Ratio falls into.



Regenetp Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Regenetp's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.0699/47.66
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenetp's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, Regenetp's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book=Book Value per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=1.696/127.3478*127.3478
=1.696

Current CPI (Mar. 2023) = 127.3478.

Regenetp Quarterly Data

Book Value per Share CPI Adj_Book
201304 641.820 98.107 833.112
201307 558.018 98.557 721.031
201310 454.820 98.536 587.812
201401 361.648 98.692 466.656
201404 287.370 100.023 365.874
201407 231.752 100.520 293.604
201410 125.759 100.176 159.871
201501 97.610 98.604 126.065
201504 -21.266 99.824 -27.130
201507 -30.400 100.691 -38.448
201510 67.013 100.346 85.045
201601 -60.851 99.957 -77.525
201604 -47.118 100.947 -59.441
201607 -41.798 101.524 -52.430
201610 -42.724 101.988 -53.348
201701 -11.742 102.456 -14.595
201704 -464.402 103.167 -573.249
201707 -439.110 103.278 -541.449
201710 -421.399 104.070 -515.656
201801 -397.206 104.578 -483.691
201804 55.256 105.708 66.568
201807 107.595 106.324 128.870
201810 95.293 106.695 113.739
201903 65.052 107.251 77.242
201906 69.756 108.070 82.200
201909 48.632 108.329 57.170
201912 35.540 108.420 41.744
202003 27.123 108.902 31.717
202006 19.201 108.767 22.481
202009 15.779 109.815 18.298
202012 12.459 109.897 14.437
202103 8.822 111.754 10.053
202106 8.288 114.631 9.207
202109 8.245 115.734 9.072
202112 5.833 117.630 6.315
202203 4.478 121.301 4.701
202206 4.032 125.017 4.107
202209 2.347 125.227 2.387
202212 2.290 125.222 2.329
202303 1.696 127.348 1.696

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Regenetp  (OTCPK:RGTPQ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Regenetp Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Regenetp's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenetp (Regenetp) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1960 South 4250 West, Salt Lake City, UT, USA, 84104
Regenetp Inc Formerly PolarityTE Inc is a clinical-stage biotechnology company developing regenerative tissue products and biomaterials. It's focused on transforming the lives of patients by discovering, designing, and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement, or regeneration of the skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.
Executives
Peter A Cohen director 40 WEST 57TH STREET, SUITE 2020, NEW YORK NY 10019
David B Seaburg director 1960 S 4250 W, SALT LAKE CITY UT 84104
Richard Hague officer: Chief Operating Officer 1960 S 4250 W, SALT LAKE CITY UT 84104
Cameron J. Hoyler other: General Counsel 1960 S 4250 W, SALT LAKE CITY UT 84104
Jeffrey Hansen Dyer director 4041-T HADLEY ROAD, SOUTH PLAINFIELD NJ 07080
Jessica Xiaolin Shen director POLARITYTE, INC. (NASDAQ: PTE), 1960 S. 4250 WEST, SALT LAKE CITY UT 84104
Chris Nolet director C/O REVANCE THERAPEUTICS, INC., 7555 GATEWAY BOULEVARD, NEWARK CA 94560
Paul Elliot Mann officer: Chief Financial Officer C/O ASP ISOTOPES INC., 433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Jacob Alexander Patterson officer: Chief Financial Officer 14822 S. ROSESCAPE CIRCLE, HERRIMAN UT 84096
Denver Lough 10 percent owner, other: Prior D&O within 90 days 4041-T HADLEY ROAD, SOUTH PLAINFIELD NJ 07080
Rainer M Erdtmann director 1073 ARLINGTON BLVD., EL CERRITO CA 94530
Edward Winslow Swanson director, officer: Chief Operating Officer 181 DANTE AVE., TUCKAHOE NY 07070
Steve Gorlin director 150 GULF SHORE DRIVE, UNIT 601, DESTIN FL 32541
Minnie Baylor-henry director C/O SCPHARMACUETICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01803
Willie C Bogan director 1943, ROSECREST DRIVE, OAKLAND CA 94602